跳到正文
原文
Medical Xpress·· 3 小时前精选AI 评分65

继续使用高级疗法可能降低择期克罗恩病手术后严重并发症风险

Continuing advanced therapies before elective Crohn's surgery may reduce serious complications

AI 导读

一项回顾性分析发现,继续使用生物制剂和小分子药物等高级疗法的克罗恩病患者在择期结直肠手术后,发生吻合口漏和器官空间手术部位感染的风险较低。研究挑战了传统观点,认为手术前应停用这些疗法。

推荐理由

研究挑战了传统手术前停用免疫抑制疗法的观点,发现继续使用高级疗法可能降低术后并发症风险。

正文 · 原文
surgery
Credit: Pixabay/CC0 Public Domain

Patients with Crohn's disease who continue advanced therapies, including biologics and small-molecule drugs, in the months before elective colorectal surgery may have a lower risk of two postoperative complications: anastomotic leak and organ space surgical site infection, according to a study published in the Journal of the American College of Surgeons.

These findings challenge previous thoughts that immunosuppressive therapies should be stopped before surgery due to concerns about postoperative complications. In contrast, advanced therapy use was associated with improved outcomes and a lower risk of anastomotic leak and organ space surgical site infection, feared complications of colorectal surgery.

The retrospective analysis from 2021 to 2024 includes 1,150 patients at 24 centers in the American College of Surgeons NSQIP-Inflammatory Bowel Disease Collaborative. After adjusting for baseline differences, anastomotic leak or organ space surgical site infection occurred in 2.43% of patients who received advanced therapy compared with 6.46% of those who did not. There was no statistically significant difference in superficial surgical site infection, deep incisional surgical site infection, or wound dehiscence.

Crohn's disease is a chronic inflammatory condition of the digestive tract that often requires surgical removal of diseased areas of the lower digestive system and reconnection of the remaining intestine, called an anastomosis. An anastomotic leak, in which a hole forms at the reconnection and poop leaks into the abdomen, is a potentially devastating complication that can require emergency reoperation or prolonged hospitalization.

Historically, the immunosuppressive nature of advanced therapies raised concerns that they might impair wound healing, similar to the well-established effects of corticosteroids.

"The previous school of thought was if a patient needs surgery, you need to stop advanced therapies beforehand, because there was concern that they would be associated with worse outcomes including weakened wound healing or anastomotic leaks," said lead author Nicholas C. Neel, MD, a surgery resident and researcher at the University of California San Diego.

"The first studies that came out seemed to support that, but as we've gotten more data, that signal isn't as strong as we thought and these data seem to suggest the opposite is true."

The study focused specifically on elective surgeries, in which patients can be optimized in advance. In urgent or emergent cases, surgery proceeds regardless of medication status. The researchers also examined Crohn's disease separately from ulcerative colitis and found the signal was concentrated in Crohn's patients. Anti-TNF agents were the most common therapy (46%), followed by anti-IL-23 (33%) and anti-integrin agents (12%).

"It was interesting that no matter how we sliced the data, there seemed to be a signal associated with the use of advanced therapies and some better outcomes," Neel said.

The authors emphasize that the findings are associative and likely reflect better disease control through reduced systemic inflammation and improved mucosal healing rather than a direct pharmacologic effect of the drugs. They call for confirmation in larger datasets with sufficient power for drug-class-specific adjusted analyses.

Publication details

Nicholas C Neel et al., Preoperative Advanced Therapy Use and Anastomotic Complications After Elective Surgery for Crohn's Disease, Journal of the American College of Surgeons (2026). DOI: 10.1097/xcs.0000000000002287

Journal information: Journal of the American College of Surgeons

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Continuing advanced therapies before elective Crohn's surgery may reduce serious complications (2026, November 20) retrieved 20 November 2026 from https://medicalxpress.com/news/2026-11-advanced-therapies-elective-crohn-surgery.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com